Senior Financial Accountant at CHAN Medi-Pharm Limited / Gte

Senior Financial Accountant at CHAN Medi-Pharm Limited / Gte. Please make sure you read the job requirements before applying for this position.

CHAN Medi-Pharm Limited / Gte, a Christian Health Association of Nigeria (CHAN) company is today the oldest and largest drug distribution NGO in Nigeria. The company has expanded to acquire a large asset base with Headquarters at Jos and six zonal drug depots within Nigeria. With a vision to be “the preferred partner in health care”, the company is seeking to recruit dynamic and performance-driven individuals to fill the following vacancies.

We are recruiting to fill the position below:

Job Title: Senior Financial Accountant

Location: Jos, Plateau
Employment Type: Full-time
Reporting to: the Managing Director

Job Description
The applicant is expected to:

• Maintain an up to date fixed asset register
• Carry out monthly bank reconciliation.
• Carry out any other assignment given from time to time.
• Prepare a timely financial report monthly, quarterly, and annually.
• Prepare annual budgets& establish budgetary control
• Ensure timely, best, and appropriate financing options for the company.
• Establish effective credit controls for customers and timely payment of suppliers
• Ensure compliance with relevant statutory authorities

Qualifications

• B.Sc / HND in Accounting, & Chartered Accountant(ACA or ACCA)
• A master’s holder in a related discipline is an added advantage.
• Expert in all accounting soft ware’s/packaging will be an added advantage
• 3-4 years experience in a similar function.
• Have excellent knowledge of MS Excel, MS Word, and PowerPoint.
• Honesty and maturity in character very essential
• Must have effective time and activity management skills, self-confidence, with the ability to work under pressure.

Method of Application

Interested and qualified candidates should send their CV and a Covering Letter to: [email protected] using the Job Title as the subject of the mail.

Application Deadline 

3rd February, 2025.